Related Experiment Video
Updated: Jan 11, 2026

08:57
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
2.5K
"Benign" Metastasizing Fibrous Histiocytoma Harboring PRKCD Gene Fusions With Malignant Clinical Course
Charlotte I Wang1, Anne B Giersch2, Santiago Lozano Calderon3
1Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Genes, Chromosomes & Cancer
|November 19, 2025
Summary
Rare aggressive fibrous histiocytomas can recur and metastasize. Recognizing these tumors and associated genetic fusions is crucial for accurate diagnosis and management.
Area of Science:
- Dermatopathology
- Oncology
- Genetics
Background:
- Dermatofibroma/fibrous histiocytoma is a common dermal tumor.
- Subtypes like cellular and aneurysmal dermatofibroma have increased recurrence risk.
- Rarely, fibrous histiocytoma exhibits aggressive behavior with recurrence and metastasis.
Purpose of the Study:
- To describe two cases of benign fibrous histiocytoma with recurrence and metastasis.
- To highlight the importance of recognizing aggressive fibrous histiocytoma.
- To correlate complex chromosomal abnormalities with aggressive clinical behavior.
Main Methods:
- Case report of two patients with recurrent and metastatic fibrous histiocytoma.
- Identification of KIRREL1::PRKCD and LAMTOR1::PRKCD fusions in the respective cases.
- Review of clinical, pathological, and radiological findings.
Main Results:
- Patient 1: Cellular fibrous histiocytoma with KIRREL1::PRKCD fusion, recurrence, and metastasis to chest wall and thigh.
- Patient 2: Aneurysmal fibrous histiocytoma with LAMTOR1::PRKCD fusion, local recurrence, lymph node, and pulmonary metastasis.
- Both cases demonstrated clinically aggressive behavior despite typical benign morphology.
Conclusions:
- Fibrous histiocytoma rarely presents with aggressive behavior, recurrence, and metastasis.
- Accurate diagnosis, multidisciplinary management, and surveillance are essential for these rare cases.
- Complex chromosomal abnormalities may indicate an increased risk of aggressive clinical behavior in fibrous histiocytoma.
Related Concept Videos
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Cancer-Critical Genes I: Proto-oncogenes
11.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.1K

